Pipeline Depth Underpinned by Multiple Indications and Platforms Invectys develops a full range of innovative and very promising immunotherapeutic oncology products…
Harnessing the potential of a novel immune checkpoint with HLA-G platform Invectys exploits a powerful immune checkpoint named HLA-G. It is found mostly at the fetal-maternal…
A DNA vaccine targeting a specific cancer marker Cancer cells produce an enzyme which is key to their unlimited proliferation, but is nearly never expressed in normal…
Using specific cancer markers to turn “cold” tumors “hot” Cells will express on their surface short protein fragments – peptides – corresponding to proteins…
